Atlas Trials

Effect of Morphine on Dyspnea and 6-Minute Walk Distance in Pulmonary Arterial Hypertension

Clinical trial NCT03401476 · UNKNOWN

Trial details

NCT number
NCT03401476
Sponsor
John Granton
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Pulmonary Arterial Hypertension
Start date
2017-05-08
Primary completion
2018-12-31
Enrollment
15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.